Sign in

CIK 0001108205

  • Non-accelerated filer
  • Smaller reporting company
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043505116
Phone
+1 617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy President & COO bought 3,000 shares at $2.52 ($7,560)
  9. 4 Open-market buy CFO bought 10,000 shares at $2.86 ($28,600)
  10. 4 Open-market buy Director bought 20,000 shares at $2.95 ($59,000)
  11. 4 Open-market buy Director bought 10,000 shares at $4.37 ($43,691)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 50,000 shares at $4.00 ($200,000)
  15. 4 Gift CFO gave 6,000 shares (gift)
  16. 4 Open-market sale CEO and Director sold 126,852 shares at an average $3.68 ($466,552)
  17. 4/A Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)
  18. 4 Exercise or conversion CFO acquired 50,000 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 62,500 shares (option exercise)
  20. 4 Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)

Page 10 of 24 · 475 filings